Beste apotheek van Nederland

Beretta G, Marzotto M, Zanollo A et al. Office treatment:
intracavernous injections of prostaglandin E1 (PG E1) and
improvement of spontaneous erections. Acta Eur Fertil
1991;22(4):221-223.
Berner M M, Kriston L, Harms A. Efficacy of PDE-5-inhibitors
for erectile dysfunction. A comparative meta-analysis of fixeddose
regimen randomized controlled trials administering the
International Index of Erectile Function in broad-spectrum
populations. Int J Impot Res 2005;
Billington C J, Shafer R B, Morley J E. Effects of opioid
blockade with nalmefene in older impotent men. Life Sci
1990;47(9):799-805.
Bird T D, Lipe H P, Crabtree L D. Impotence associated with
the Charcot-Marie-Tooth syndrome. Eur Neurol
1994;34(3):155-157.
Bischoff E. Vardenafil preclinical trial data: Potency,
pharmacodynamics, pharmacokinetics, and adverse events. Int J
Impot Res 2004;16(SUPPL. 1):S34-S37.
Black A M, Day A G, Morales A. The reliability of clinical and
biochemical assessment in symptomatic late-onset
hypogonadism: Can a case be made for a 3-month therapeutic
trial?. BJU Int 2004;94(7):1066-1070.
Blanker M H, Thomas S, Bohnen A M. Systematic review of
Viagra RCTs. Br J Gen Pract 2002;52(477):329
Blonde L. Sildenafil citrate for erectile dysfunction in men with
diabetes and cardiovascular risk factors: a retrospective analysis
of pooled data from placebo-controlled trials. Curr Med Res
Opin 2006;22(11):2111-2120.
Bocchi E A, Guimaraes G, Mocelin A et al. Sildenafil effects on
exercise, neurohormonal activation, and erectile dysfunction in
congestive heart failure: a double-blind, placebo-controlled,
randomized study followed by a prospective treatment for
erectile dysfunction. Circulation 2002;106(9):1097-1103.
Bodansky H J E. Successful tadalafil treatment for erectile
dysfunction associated with Charcot-Marie-Tooth syndrome.
[References]. Sexual and Relationship Therapy 2006;21(1):87­
89.
Bolona E R, Uraga M V, Haddad R M et al. Testosterone use in
men with sexual dysfunction: a systematic review and metaanalysis
of randomized placebo-controlled trials. Mayo Clin
Proc 2007;82(1):20-28.
Bouloux P. Testim 1% testosterone gel for the treatment of male
hypogonadism. [Review] [33 refs]. Clin Ther 2005;27(3):286­
298.
Boyarsky B K, Haque W, Rouleau M R et al. Sexual functioning
in depressed outpatients taking mirtazapine. Depression &
Anxiety 1999;9(4):175-179.
Braatvedt G D. Outcome of managing impotence in clinical
practice. N Z Med J 1999;112(1092):272-274.
Brazil M. Viagra for broken hearts?. Nat Rev Genet
2005;4(3):190
Briganti A, Salonia A, Gallina A et al. Drug insight:
Oral phosphodiesterase type 5 inhibitors for erectile
dysfunction. Nature Clinical Practice Urology
2005;2(5):239-247.
Brignardello E, Manti R, Papotti M et al. Ectopic
secretion of LH by an endocrine pancreatic tumor. J
Endocrinol Invest 2004;27(4):361-365.
Brindis R G, Kloner R A. Sildenafil in patients with
cardiovascular disease. [Review] [33 refs]. Am J
Cardiol 2003;92(9A):26M-36M.
Brisson T E, Broderick G A, Thiel D D et al.
Vardenafil rescue rates of sildenafil nonresponders:
objective assessment of 327 patients with erectile
dysfunction. Urology 2006;68(2):397-401.
Brock G B, McMahon C G, Chen K K et al. Efficacy
and safety of tadalafil for the treatment of erectile
dysfunction: results of integrated analyses. Br J Urol
2002;168(4 Pt 1):1332-1336.
Brock G, Chan J, Carrier S et al. The treatment of
erectile dysfunction study: focus on treatment
satisfaction of patients and partners. BJU Int
2007;99(2):376-382.
Brown S L, Haas C A, Koehler M et al.
Hepatotoxicity related to intracavernous
pharmacotherapy with papaverine. Urology
1998;52(5):844-847.
Buddeberg C, Bucher T, Hornung R. [Erectile
dysfunction in men in their second half of life].
Urologe 2005;Ausg. A. 44(9):1045-1046, 1048-51.
Burge M R, Lanzi R A, Skarda S T et al. Idiopathic
hypogonadotropic hypogonadism in a male runner is
reversed by clomiphene citrate. Fertility & Sterility
1997;67(4):783-785.
Burls A, Gold L, Clark W. Systematic review of
randomised controlled trials of sildenafil (Viagra) in
the treatment of male erectile dysfunction. Br J
Gen.Pract. 2001;51(473):1004-1012.
Burnett A L. Vasoactive pharmacotherapy to cure
erectile dysfunction: fact or fiction?. [Review] [45
refs]. Urology 2005;65(2):224-230.
Burns-Cox N, Gingell C. The andropause: fact or
fiction?. [Review] [49 refs]. Postgrad Med J
1997;73(863):553-556.
Buvat J. Hyperprolactinemia and sexual function in
men: a short review. [Review] [26 refs]. Int J Impot
Res 2003;15(5):373-377.
D-101